Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In: Goldstein I, Traish A, Davis S, Meston C (eds)
If you'd like to opt out of cookies, please go to the Network Advertising Initiative website (opens in a new window)
J Clin Nurs
collapse Signs of sepsis: high fever or very low temperature, rapid breathing, confusion, or feeling extremely unwell following an injection Severe hypoglycaemia with loss of consciousness or inability to swallow Severe chest pain or significant difficulty breathing Contact your GP or a healthcare professional promptly if you experience: Injection site reactions such as persistent redness, swelling, warmth, or pain, which may indicate infection or an inflammatory response Systemic symptoms including fever, chills, or malaise following administration Gastrointestinal symptoms such as severe or persistent nausea, vomiting, or abdominal pain these are known effects associated with GLP-1 receptor agonism and may require clinical assessment [15] [6] Symptoms of hypoglycaemia shakiness, sweating, confusion, or palpitations particularly if retatrutide is being used alongside other glucose-lowering agents Cardiovascular symptoms such as a rapid or irregular heartbeat Report suspected side effects via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
PubMed Related Resources Retatrutide Hub Complete retatrutide guide: mechanism, trial data, side effects, and forecasts
US$ 22.55
US$ 21.80
US$ 20.62
US$ 21.59
US$ 23.72
US$ 22.40
US$ 29.88
US$ 29.67
